Encyclopedia

  • Stobadine inhibits lysosomal enzyme release in vivo and in vitro
  • Add time:09/08/2019         Source:sciencedirect.com

    This study investigated the ability of stobadine, an effective cardioprotective drug with antiarrhythmic, antihypoxic and oxygen free radical scavenging properties, to protect cells against cyclophosphamide-induced toxic and cytotoxic damage in vivo and in vitro. Cyclophosphamide-induced toxic damage in female ICR mice was accompanied by marked increase in the activity of lysosomal enzymes in the spleen and kidney. Administration of stobadine prior to cyclophosphamide inhibited these biochemical changes. The in vivo protective effect of stobadine was comparable with its in vitro effect established in HeLa cells.

    We also recommend Trading Suppliers and Manufacturers of stobadine N-oxide (cas 108331-06-2). Pls Click Website Link as below: cas 108331-06-2 suppliers


    Prev:Stobadine and heart mitochondria
    Next: Stobadine: Bellwether of a broader view of drug actions)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View